| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
124,070,000 |
| Market
Cap: |
137.72(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.5599 - $6.19 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Seres Therapeutics is a microbiome therapeutics platform company developing live biotherapeutic drugs. SER-109, Co.'s lead clinical candidate is an oral, purified bacterial spore-based microbiome therapeutic candidate consisting of a consortium of purified Firmicutes spores. Using Co.'s microbiome therapeutics platform, Co. is also developing SER-287 and SER-301 to treat ulcerative colitis. Co. evaluates microbiome pharmacokinetic and pharmacodynamic data from across its clinical and pre-clinical portfolios using its reverse translation microbiome therapeutics capabilities to conduct research on various indications, including inflammatory and immune diseases, cancer, and metabolic diseases.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
8,738,243 |
| Total Buy Value |
$0 |
$0 |
$0 |
$27,525,465 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
36,381 |
36,381 |
71,150 |
83,200 |
| Total Sell Value |
$39,292 |
$39,292 |
$86,229 |
$162,501 |
| Total People Sold |
7 |
7 |
8 |
8 |
| Total Sell Transactions |
7 |
7 |
15 |
17 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Pomerantz Roger |
President and CEO |
• • – |
2018-09-06 |
4 |
AS |
$9.04 |
$27,235 |
D/D |
(3,013) |
215,786 |
|
- |
|
| Pomerantz Roger |
President and CEO |
• • – |
2018-09-05 |
4 |
AS |
$9.12 |
$86,714 |
D/D |
(9,505) |
218,799 |
|
- |
|
| Aunins John G. |
See Remarks |
• – – |
2018-08-15 |
4 |
AS |
$7.57 |
$108,069 |
D/D |
(14,279) |
132,369 |
|
- |
|
| Aunins John G. |
Chief Technology Officer & EVP |
• – – |
2018-07-15 |
4 |
AS |
$8.10 |
$115,726 |
D/D |
(14,279) |
160,927 |
|
- |
|
| Pomerantz Roger |
President and CEO |
• • – |
2018-07-11 |
4 |
AS |
$9.01 |
$9,099 |
D/D |
(1,010) |
228,304 |
|
- |
|
| Pomerantz Roger |
President and CEO |
• • – |
2018-07-11 |
4 |
OE |
$0.71 |
$717 |
D/D |
1,010 |
229,314 |
|
- |
|
| Pomerantz Roger |
President and CEO |
• • – |
2018-07-10 |
4 |
AS |
$9.05 |
$54,208 |
D/D |
(5,989) |
228,304 |
|
- |
|
| Pomerantz Roger |
President and CEO |
• • – |
2018-07-10 |
4 |
OE |
$0.71 |
$4,252 |
D/D |
5,989 |
234,293 |
|
- |
|
| Pomerantz Roger |
President and CEO |
• • – |
2018-07-09 |
4 |
AS |
$9.14 |
$100,351 |
D/D |
(10,981) |
228,304 |
|
- |
|
| Pomerantz Roger |
President and CEO |
• • – |
2018-07-09 |
4 |
OE |
$0.71 |
$7,797 |
D/D |
10,981 |
239,285 |
|
- |
|
| Pomerantz Roger |
President and CEO |
• • – |
2018-07-06 |
4 |
AS |
$9.14 |
$140,507 |
D/D |
(15,366) |
228,304 |
|
- |
|
| Pomerantz Roger |
President and CEO |
• • – |
2018-07-06 |
4 |
OE |
$0.71 |
$10,910 |
D/D |
15,366 |
243,670 |
|
- |
|
| Pomerantz Roger |
President and CEO |
• • – |
2018-06-29 |
4 |
AS |
$9.10 |
$40,915 |
D/D |
(4,496) |
228,304 |
|
- |
|
| Pomerantz Roger |
President and CEO |
• • – |
2018-06-29 |
4 |
OE |
$0.71 |
$3,192 |
D/D |
4,496 |
232,800 |
|
- |
|
| Pomerantz Roger |
President and CEO |
• • – |
2018-06-28 |
4 |
AS |
$9.15 |
$197,375 |
D/D |
(21,560) |
228,304 |
|
- |
|
| Pomerantz Roger |
President and CEO |
• • – |
2018-06-28 |
4 |
OE |
$0.71 |
$15,308 |
D/D |
21,560 |
249,864 |
|
- |
|
| Pomerantz Roger |
President and CEO |
• • – |
2018-06-27 |
4 |
AS |
$9.03 |
$153,408 |
D/D |
(16,991) |
228,304 |
|
- |
|
| Pomerantz Roger |
President and CEO |
• • – |
2018-06-27 |
4 |
OE |
$0.71 |
$12,064 |
D/D |
16,991 |
245,295 |
|
- |
|
| Pomerantz Roger |
President and CEO |
• • – |
2018-06-26 |
4 |
AS |
$9.19 |
$195,133 |
D/D |
(21,224) |
228,304 |
|
- |
|
| Pomerantz Roger |
President and CEO |
• • – |
2018-06-26 |
4 |
OE |
$0.71 |
$15,069 |
D/D |
21,224 |
249,528 |
|
- |
|
| Pomerantz Roger |
President and CEO |
• • – |
2018-06-25 |
4 |
AS |
$9.21 |
$246,504 |
D/D |
(26,752) |
228,304 |
|
- |
|
| Pomerantz Roger |
President and CEO |
• • – |
2018-06-25 |
4 |
OE |
$0.71 |
$11,564 |
D/D |
16,288 |
255,056 |
|
- |
|
| Pomerantz Roger |
President and CEO |
• • – |
2018-06-22 |
4 |
AS |
$9.36 |
$374,761 |
D/D |
(40,057) |
238,768 |
|
- |
|
| Pomerantz Roger |
President and CEO |
• • – |
2018-06-21 |
4 |
AS |
$9.06 |
$172,094 |
D/D |
(18,987) |
278,825 |
|
- |
|
| Pomerantz Roger |
President and CEO |
• • – |
2018-06-20 |
4 |
AS |
$9.33 |
$247,051 |
D/D |
(26,492) |
297,812 |
|
- |
|
195 Records found
|
|
Page 4 of 8 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.08 (6.72%) 
